1. Home
  2. VERU vs YSXT Comparison

VERU vs YSXT Comparison

Compare VERU & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • YSXT
  • Stock Information
  • Founded
  • VERU 1971
  • YSXT 2011
  • Country
  • VERU United States
  • YSXT China
  • Employees
  • VERU N/A
  • YSXT N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • YSXT Automotive Aftermarket
  • Sector
  • VERU Health Care
  • YSXT Consumer Discretionary
  • Exchange
  • VERU Nasdaq
  • YSXT Nasdaq
  • Market Cap
  • VERU 54.6M
  • YSXT 58.6M
  • IPO Year
  • VERU 1990
  • YSXT 2024
  • Fundamental
  • Price
  • VERU $2.88
  • YSXT $2.97
  • Analyst Decision
  • VERU Strong Buy
  • YSXT
  • Analyst Count
  • VERU 3
  • YSXT 0
  • Target Price
  • VERU $33.33
  • YSXT N/A
  • AVG Volume (30 Days)
  • VERU 182.9K
  • YSXT 157.9K
  • Earning Date
  • VERU 12-15-2025
  • YSXT 07-31-2025
  • Dividend Yield
  • VERU N/A
  • YSXT N/A
  • EPS Growth
  • VERU N/A
  • YSXT N/A
  • EPS
  • VERU N/A
  • YSXT 0.18
  • Revenue
  • VERU $16,886,419.00
  • YSXT $71,452,736.00
  • Revenue This Year
  • VERU N/A
  • YSXT N/A
  • Revenue Next Year
  • VERU N/A
  • YSXT N/A
  • P/E Ratio
  • VERU N/A
  • YSXT $14.76
  • Revenue Growth
  • VERU 337.24
  • YSXT 22.04
  • 52 Week Low
  • VERU $2.64
  • YSXT $1.68
  • 52 Week High
  • VERU $14.20
  • YSXT $9.96
  • Technical
  • Relative Strength Index (RSI)
  • VERU 32.50
  • YSXT 62.92
  • Support Level
  • VERU $2.76
  • YSXT $2.35
  • Resistance Level
  • VERU $3.99
  • YSXT $3.00
  • Average True Range (ATR)
  • VERU 0.29
  • YSXT 0.19
  • MACD
  • VERU -0.17
  • YSXT 0.06
  • Stochastic Oscillator
  • VERU 11.23
  • YSXT 95.77

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

Share on Social Networks: